Compare Moderna, Inc. (MRNA) vs YieldMax Universe Fund of Option Income ETFs (YMAX) Price & Performance

Moderna, Inc.Trade

YieldMax Universe Fund of Option Income ETFsTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs YieldMax Universe Fund of Option Income ETFs — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while YieldMax Universe Fund of Option Income ETFs trades at $7.72. The key difference: Moderna, Inc. is trading nearer its 52-week high, YieldMax Universe Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals.

	MRNA	YMAX
Market Cap	$23.60B	—
Sector	Health	Income / Options Overlay
52-Week High	$81.80	$14.00
52-Week Low	$22.36	$7.51
Enterprise Value	$19.70B	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 13 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

YMAX

YieldMax ETFs declare weekly distributions for multiple option income ETFs starting July 23, 2026.Na · 11 hours agoNeutral View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About YieldMax Universe Fund of Option Income ETFs

YMAX is an actively managed 'fund of funds' that provides equal-weighted exposure to the full suite of YieldMax option income ETFs. It is designed to generate high current income by aggregating the premiums from various single-stock and thematic covered call strategies, offering a diversified approach to high-yield option investing.